[1] J. Jeevanandam, A. Barhoum, Y. S. Chan, A. Dufresne, and M. K. Danquah, “Review on nanoparticles and nanostructured materials: History, sources, toxicity and regulations,” Beilstein Journal of Nanotechnology, vol. 9, no. 1. Beilstein-Institut Zur Forderung der Chemischen Wissenschaften, pp. 1050–1074, 03-Apr-2018.
[2] R. Dobrucka, “Selected applications of metal nanoparticles in medicine and pharmacology,” LogForum, vol. 15, no. 4, pp. 449–457, 2019.
[3] K. Khalid et al., “Advanced in developmental organic and inorganic nanomaterial: a review,” Bioengineered, vol. 11, no. 1, pp. 328–355, Jan. 2020.
[4] A. Ali et al., “Review on Recent Progress in Magnetic Nanoparticles: Synthesis, Characterization, and Diverse Applications,” Frontiers in Chemistry, vol. 9. Frontiers Media S.A., p. 548, 13-Jul-2021.
[5] I. Khan, K. Saeed, and I. Khan, “Nanoparticles: Properties, applications and toxicities,” Arabian Journal of Chemistry, vol. 12, no. 7. Elsevier B.V., pp. 908–931, 01-Nov-2019.
[6] S. Sharma, S. Jaiswal, B. Duffy, and A. K. Jaiswal, “Nanostructured Materials for Food Applications: Spectroscopy, Microscopy and Physical Properties,” Bioengineering, vol. 6, no. 1. MDPI AG, 01-Mar-2019.
[7] A. Staroń, O. Długosz, J. Pulit-Prociak, and M. Banach, “Analysis of the Exposure of Organisms to the Action of Nanomaterials,” Materials (Basel)., vol. 13, no. 2, p. 349, Jan. 2020.
[8] J. K. Patra et al., “Nano based drug delivery systems: Recent developments and future prospects ,” Journal of Nanobiotechnology, vol. 16, no. 1. BioMed Central Ltd., p. 71, 19-Sep-2018.
[9] A. Chowdhury, S. Kunjiappan, T. Panneerselvam, B. Somasundaram, and C. Bhattacharjee, “Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases,” Int. Nano Lett., vol. 7, no. 2, pp. 91–122, Jun. 2017.
[10] Y. Peng et al., “Research and development of drug delivery systems based on drug transporter and nano-formulation,” Asian Journal of Pharmaceutical Sciences, vol. 15, no. 2. Shenyang Pharmaceutical University, pp. 220–236, 01-Mar-2020.
[11] P. Boisseau and B. Loubaton, “Nanomedicine, Nanotechnology in medicine,” Jun. 2011.
[12] A. Ulldemolins et al., “Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics,” Cancer Drug Resistance, vol. 4, no. 1. OAE Publishing Inc., pp. 44–68, 19-Mar-2021.
[13] G. Tiwari et al., “Drug delivery systems: An updated review,” Int. J. Pharm. Investig., vol. 2, no. 1, p. 2, 2012.
[14] G. T. Mazitova, K. I. Kienskaya, D. A. Ivanova, I. A. Belova, I. A. Butorova, and M. V. Sardushkin, “Synthesis and Properties of Zinc Oxide Nanoparticles: Advances and Prospects,” Rev. J. Chem., vol. 9, no. 2, pp. 127–152, Apr. 2019.
[15] S. Thiagarajan, A. Sanmugam, and D. Vikraman, “Facile Methodology of Sol-Gel Synthesis for Metal Oxide Nanostructures,” in Recent Applications in Sol-Gel Synthesis, InTech, 2017.
[16] I. Litzov and C. Brabec, “Development of Efficient and Stable Inverted Bulk Heterojunction (BHJ) Solar Cells Using Different Metal Oxide Interfaces,” Materials (Basel)., vol. 6, no. 12, pp. 5796–5820, Dec. 2013.
[17] M. A. Moghri Moazzen, S. M. Borghei, and F. Taleshi, “Change in the morphology of ZnO nanoparticles upon changing the reactant concentration,” Appl. Nanosci., vol. 3, no. 4, pp. 295–302, Aug. 2013.
[18] A. Yoo, M. Lin, and A. Mustapha, “Zinc oxide and silver nanoparticle effects on intestinal bacteria,” Materials (Basel)., vol. 14, no. 10, p. 2489, May 2021.
[19] R. Brayner, R. Ferrari-Iliou, N. Brivois, S. Djediat, M. F. Benedetti, and F. Fiévet, “Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium,” Nano Lett., vol. 6, no. 4, pp. 866–870, Apr. 2006.
[20] B. Lallo da Silva et al., “Relationship Between Structure And Antimicrobial Activity Of Zinc Oxide Nanoparticles: An Overview</p>,” Int. J. Nanomedicine, vol. Volume 14, pp. 9395–9410, Dec. 2019.
[21] E. Friehs et al., “Toxicity, phototoxicity and biocidal activity of nanoparticles employed in photocatalysis,” Journal of Photochemistry and Photobiology C: Photochemistry Reviews, vol. 29. Elsevier B.V., pp. 1–28, 01-Dec-2016.
[22] I. Sur, D. Cam, M. Kahraman, A. Baysal, and M. Culha, “Interaction of multi-functional silver nanoparticles with living cells,” Nanotechnology, vol. 21, no. 17, Apr. 2010.
[23] N. Ivanova, V. Gugleva, M. Dobreva, I. Pehlivanov, S. Stefanov, and V. Andonova, “Silver Nanoparticles as Multi-Functional Drug Delivery Systems,” in Nanomedicines, IntechOpen, 2019.
[24] D. C. Kennedy et al., “Carbohydrate functionalization of silver nanoparticles modulates cytotoxicity and cellular uptake,” J. Nanobiotechnology, vol. 12, no. 1, p. 59, Dec. 2014.
[25] C. G. Liu, Y. H. Han, R. K. Kankala, S. Bin Wang, and A. Z. Chen, “Subcellular performance of nanoparticles in cancer therapy,” Int. J. Nanomedicine, vol. 15, pp. 675–704, Feb. 2020.
[26] M. Sousa De Almeida, E. Susnik, B. Drasler, P. Taladriz-Blanco, A. Petri-Fink, and B. Rothen-Rutishauser, “Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine,” Chemical Society Reviews, vol. 50, no. 9. Royal Society of Chemistry, pp. 5397–5434, 07-May-2021.
[27] B. Harper et al., “The Impact of Surface Ligands and Synthesis Method on the Toxicity of Glutathione-Coated Gold Nanoparticles,” Nanomaterials, vol. 4, no. 2, pp. 355–371, May 2014.